Rudkin Research is an online database of cutting edge research with source cited material created in loving memory of Greg Rudkin.
When Greg Rudkin was diagnosed with myelodysplasia, a bone marrow disorder, his family immediately flew him from his home in Florida to Dana-Farber Cancer Institute, where he was treated by Edwin P. Alyea III, MD.
The care Greg received from Alyea and his entire team prompted a generous $120,000 gift from the Rudkin family and The Harry E. Goldfarb Family Foundation to establish the Greg Rudkin Stem Cell Transplant Research Fund to support Alyea’s research. Alyea’s work is focused on using allogeneic transplants to treat older patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Generally, the genetic alterations in cancer cells can predict the risk of relapse after transplantation. “This gift will support our efforts to better understand the relationship between these genetic alterations and the risk of relapse,” said Alyea. “By understanding which patients are at a higher risk of relapse, we can develop new strategies using the immune system to reduce that risk.” Dana-Farber holds a special place in the hearts of Greg’s family.
The establishment of this memorial fund not only honors Greg’s life and his fight, but also reflects the appreciation for the understanding, compassion, and positivity the staff and faculty shared. “From our very first meeting at Dana-Farber, it was evident that they saw Greg not only as a patient, but as an individual,” said Janice Lindsey, Greg’s wife. “Dana-Farber, Dr. Alyea, and his entire team understood the need to balance living one’s life while battling cancer, and we give them our sincerest thanks.”